Segments - Artificial Intelligence in Remote Patient Monitoring Market by Component (Software Solutions and Hardware Devices), Technology (Machine Learning, Natural Language Processing, Computer Vision, Predictive Analytics, and Deep Learning), Application (Chronic Disease Management, Post-acute Care Monitoring, Elderly Care Monitoring, Cardiovascular Monitoring, Diabetes Management, Neurological Monitoring, Respiratory Monitoring, and Others), End-user (Hospitals & Clinics, Home Care Settings, Assisted Living Facilities, Nursing Homes, and Ambulatory Care Centers), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2024–2032
The global artificial intelligence in remote patient monitoring market size was USD 2.3 Billion in 2023 and is projected to reach USD 18.1 Billion by 2032, expanding at a CAGR of 25.8% during 2024–2032. The market growth is attributed to the rising prevalence of chronic diseases and increasing demand for remote healthcare solutions.
The healthcare sector is transforming due to the integration of artificial intelligence (AI) with telehealth and remote patient monitoring (RPM) devices, which improves patient care, boosts productivity, and facilitates early intervention. Telehealth and RPM devices use technology to remotely monitor the health problems of patients, thereby reducing the need for frequent in-person visits. The integration of AI algorithms enhances the capabilities of remote patient monitoring devices by evaluating enormous volumes of patient data to find patterns, abnormalities, and possible problems.
AI algorithms are essential for the early detection of disease, as they analyze enormous volumes of patient data gathered from wearables and sensors. This data includes vital indicators such as blood pressure, heart rate, and breathing rate. After processing this data, AI models create unique baselines for every patient, taking into consideration their age, gender, medical history, and current state of health. Once these baselines are set, the AI system keeps an eye out for changes from the usual incoming data.
AI-enabled remote patient monitoring offers benefits such as timely intervention, reduced hospitalizations, improved patient outcomes, and data-driven insights. It detects subtle health changes, preventing progression and complications, and enables home care, resulting in cost savings for patients and healthcare systems. This data-driven approach also informs treatment plans and lifestyle recommendations.
Rising prevalence of chronic disease is expected to drive the global market during the forecast period. Chronic illnesses such as diabetes and heart or respiratory disease require continuous monitoring in severe conditions, thereby fueling the demand for efficient and cost-effective monitoring solutions.
In 2021, the World Health Organization stated that about 63% of all deaths worldwide are caused by chronic conditions. Chronic disease is one of the major causes of death.
Increasing demand for remote healthcare solutions, such as telehealth, is boosting the market. The growing popularity of telehealth services creates a need for integrated remote patient monitoring solutions, which reduces the need for frequent hospital visits. This is beneficial for patients in remote areas or those with mobility limitations.
Advancements in AI technology are anticipated to propel the market in the coming years, as the demand for enhanced data analytics, which are able to analyze vast amounts of patient data from various sources, including wearable devices, electronic health records (EHRs), and patient-reported outcomes, is increasing in the healthcare sector. Machine learning algorithms continuously learn and improve their ability to identify patterns and anomalies in patient data. This leads to accurate and early detection of health problems and efficient use of healthcare resources. Furthermore, the growing popularity of wearable devices, such as smart watches and fitness trackers, helps patients to record their health data and vitals in real-time, thereby propelling the market.
Growing concerns about data security and privacy of sensitive data collected through AI is restraining the market. Robust cybersecurity measures are essential to gain patient trust and ensure regulatory compliance.
High cost of remote healthcare solutions empowered by AI is hampering the market. Some patient monitoring devices are expensive and not everyone can avail of them, especially patients with low- or middle-income levels. The high initial investments required for AI infrastructure and service and the absence of alternatives further hinder the market.
Integration of AI into diagnostic devices creates immense opportunities in the market. Incorporating AI into advanced sensors and diagnostics, such as smart wearables and home-based diagnostics, enable the real time monitoring of complex health parameters. This allows early detection of chronic conditions, such as heart failure and respiratory problems. Furthermore, AI-powered patient engagement and behavior change in which AI goes beyond monitoring the vital signs to analyze patient behavior patterns as well as offer personalized recommendations for lifestyle modification fuels the market.
Predictive analytics and risk stratification allow healthcare providers to prioritize care and intervene proactively, potentially preventing adverse events and improving patient outcomes. AI algorithms analyze a large number of datasets to identify patients at high risk of complications or hospital readmission.
AI-powered mental health monitoring is expected to boost the market during the forecast period. This allows the analysis of speech patterns and facial expressions to identify the potential signs of depression, anxiety, or other mental health concerns. Mental health has become a global concern. Mental health prediction and real-time detection help reduce the global burden of depression and suicidal rates.
For instance, Aiberry is a creative mental health assessment tool that provides a quantified risk score and other health insights in real-time. It uses cutting-edge AI technology to analyze user text, audio, and video clues during a brief discussion.
The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics are included in the report.
Attributes |
Details |
Report Title |
Artificial Intelligence in Remote Patient Monitoring Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2023 |
Historic Data |
2017 -2022 |
Forecast Period |
2024–2032 |
Segmentation |
Component (Software Solutions and Hardware Devices), Technology (Machine Learning, Natural Language Processing, Computer Vision, Predictive Analytics, and Deep Learning), Application (Chronic Disease Management, Post-acute Care Monitoring, Elderly Care Monitoring, Cardiovascular Monitoring, Diabetes Management, Neurological Monitoring, Respiratory Monitoring, and Others), and End-users (Hospitals and Clinics, Home Care Settings, Assisted Living Facilities, Nursing Homes, and Ambulatory Care Centers) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
Key Players Covered in the Report |
Aicure; Binah.Ai; Biofourmis; Care.Ai Inc.; Connect America LLC; Current Health; Healthsaas Inc.; Implicity; Maya Md; and Somatix Inc. |
Based on component, the market is bifurcated into software solutions and hardware devices. The software solutions segment held a major share of the market in 2023 owing to its core functionalities, such as machine learning, data analytics tools, and decision-making tools. Furthermore, the flexibility and scalability offered by software for different patient health matrices are boosting the segment. Additionally, the evolving technologies and focus on data analysis & intelligence are improving the capabilities of software solutions.
In March 2022, Microsoft Corp. announced the acquisition of Nuance Communications Inc. for affordable and accessible healthcare services to assist organizations in providing personalized customer experience.
On the basis of technology, the global market is segregated into machine learning, natural language processing, computer vision, predictive analytics, and deep learning. The machine learning segment held a large market share in 2023 and is expected to expand at a rapid pace in the coming years. AI-powered RPM systems utilize machine learning algorithms to analyze large amounts of patient data from wearables, health records, and reports. This analysis helps identify trends, detect anomalies, predict future health risks, and provide personalized medication and lifestyle recommendations.
The versatility and adaptability of machine learning algorithms continuously improve device performance, thereby driving the segment. Furthermore, the rising adoption of machine learning algorithms in data analysis due to their versatility fuels the segment.
Based on segment, the artificial intelligence in the remote patient monitoring market is segmented into chronic disease management, post-acute care monitoring, elderly care monitoring, cardiovascular monitoring, diabetes management, neurological monitoring, respiratory monitoring, and others. The chronic disease monitoring segment is anticipated to expand at a considerable CAGR during the assessment period due to the rising prevalence of chronic conditions, such as diabetes, heart risks, and respiratory illness. Moreover, AI-powered RPM aids in chronic disease management, which reduces hospital readmission rates, minimizes overall healthcare costs, and improves patient quality of life.
On the basis of end-users, the market is divided into hospitals and clinics, home care settings, assisted living facilities, nursing homes, and ambulatory care centers. The home care settings segment held a major share of the market in 2023 and is projected to grow rapidly during the forecast period due to the growing demand for remote healthcare and the increasing geriatric population.
AI-based remote patient monitoring systems are well-suited for home care settings to continuously monitor vitals, early detection of health-related concerns, and remote consultations. However, home care is beneficial for managing chronic conditions, as it reduces frequent hospital visits, thereby boosting the segment.
In terms of region, the global artificial intelligence in remote patient monitoring market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America held a major market share in 2023 and is expected to register a considerable CAGR during the projection period due to the presence of the advanced healthcare sector and the growing geriatric population in the region.
According to an article published by the Journal of Market Access & Health Policy on May 3, 2023, the rising geriatric population in the US drives the demand for healthcare services. The number of people ages 65 and above is expected to increase from 54 million in 2021 to 85.7 million by 2050.
The adoption of various remote patient monitoring devices and software fuels the market in this region. Moreover, the robust investments in research and development, well-established healthcare infrastructure, and widespread adoption of AI in healthcare systems boost the market in North America.
The artificial intelligence in remote patient monitoring market has been segmented on the basis of
Key players competing in the global artificial intelligence in remote patient monitoring market are Aicure; Binah.Ai; Biofourmis; Care.Ai Inc.; Connect America LLC; Current Health; Healthsaas Inc.; Implicity; Maya Md; and Somatix Inc.
These players adopt several development strategies to boost their global presence. For instance,
In July 2023, BPGbio entered into a collaboration with VELL Health, a frontrunner in technological wellness and holistic health, and introduced an advanced holistic and wellness application for people with Type 2 diabetes in Guyana.
In March 2023, Nanox.AI announced a strategic partnership with Ferrum Health to broaden the aspects of Nanox AI technology for medical imaging with Nanox.